We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA GRANTS APPROVABLE LETTER TO ANDRX'S NEW MANIA DRUG
FDA GRANTS APPROVABLE LETTER TO ANDRX'S NEW MANIA DRUG
January 27, 2004
Andrx has received conditional approval for its new mania and seizure treatment valproate delayed-release tablets, which is similar to brand firm Abbott Laboratories’ profitable drug Depakote.